Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment.
Saved in:
| Title: | Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment. |
|---|---|
| Authors: | Jennings VA; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Rumbold-Hall R; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Migneco G; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Barr T; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Reilly K; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Ingram N; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., St Hilare I; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Heaton S; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Alzamel N; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Jackson D; Leeds Cancer Centre, St James's Hospital, Leeds, United Kingdom., Ralph C; Leeds Cancer Centre, St James's Hospital, Leeds, United Kingdom., Banerjee S; The Royal Marsden Hospital, Fulham Road, London, United Kingdom., McNeish I; Department of Cancer and Surgery, Imperial College London, London, United Kingdom., Bell JC; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Melcher AA; The Institute of Cancer Research, Divisions of Radiotherapy and Imaging and Breast Cancer Research, Chester Beatty Laboratories, London, United Kingdom., Ilkow C; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Cook GP; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Errington-Mais F; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Dec 23; Vol. 15, pp. 1500570. Date of Electronic Publication: 2024 Dec 23 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39763667 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jennings+VA%22">Jennings VA</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rumbold-Hall+R%22">Rumbold-Hall R</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Migneco+G%22">Migneco G</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barr+T%22">Barr T</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Reilly+K%22">Reilly K</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ingram+N%22">Ingram N</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22St+Hilare+I%22">St Hilare I</searchLink>; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Heaton+S%22">Heaton S</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Alzamel+N%22">Alzamel N</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jackson+D%22">Jackson D</searchLink>; Leeds Cancer Centre, St James's Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ralph+C%22">Ralph C</searchLink>; Leeds Cancer Centre, St James's Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Banerjee+S%22">Banerjee S</searchLink>; The Royal Marsden Hospital, Fulham Road, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McNeish+I%22">McNeish I</searchLink>; Department of Cancer and Surgery, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bell+JC%22">Bell JC</searchLink>; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Melcher+AA%22">Melcher AA</searchLink>; The Institute of Cancer Research, Divisions of Radiotherapy and Imaging and Breast Cancer Research, Chester Beatty Laboratories, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ilkow+C%22">Ilkow C</searchLink>; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Cook+GP%22">Cook GP</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Errington-Mais+F%22">Errington-Mais F</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Dec 23; Vol. 15, pp. 1500570. <i>Date of Electronic Publication: </i>2024 Dec 23 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39763667 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1500570 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1500570 Titles: – TitleFull: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jennings VA – PersonEntity: Name: NameFull: Rumbold-Hall R – PersonEntity: Name: NameFull: Migneco G – PersonEntity: Name: NameFull: Barr T – PersonEntity: Name: NameFull: Reilly K – PersonEntity: Name: NameFull: Ingram N – PersonEntity: Name: NameFull: St Hilare I – PersonEntity: Name: NameFull: Heaton S – PersonEntity: Name: NameFull: Alzamel N – PersonEntity: Name: NameFull: Jackson D – PersonEntity: Name: NameFull: Ralph C – PersonEntity: Name: NameFull: Banerjee S – PersonEntity: Name: NameFull: McNeish I – PersonEntity: Name: NameFull: Bell JC – PersonEntity: Name: NameFull: Melcher AA – PersonEntity: Name: NameFull: Ilkow C – PersonEntity: Name: NameFull: Cook GP – PersonEntity: Name: NameFull: Errington-Mais F IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 12 Text: 2024 Dec 23 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |